Cipla Shares Rise 10% After USFDA Paves Way For Abraxane Drug Launch
Cipla Ltd. shares jumped over 10 per cent in early trading on Thursday after the USFDA classified its Goa facility as a VIA status
Cipla Ltd. shares jumped over 10 per cent in early trading on Thursday after the USFDA classified its Goa facility as a VIA status
What's Your Reaction?
Subhashree
Hi, This is Subhi.
Welcome to my blog! I love to keep up with the latest news in healthcare, technology and media. Here you will find insightful articles that inform and interest you about the world around you. Join me as I drift between health and technology, and stay up-to-date!
